Several studies have also demonstrated that the genetic variants of TCF7L2 that drive T2D risk also increase susceptibility to cystic fibrosis-related diabetes (CFRD) [115–117]. This evidence concerns the gene TCF7L2 and cystic fibrosis-related diabetes.